Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.01
(-0.74%)
CNY 4.01
(-0.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 62.25 Million CNY | 99.3% |
| 2022 | 31.23 Million CNY | -81.07% |
| 2021 | 165.01 Million CNY | 27.83% |
| 2020 | 129.09 Million CNY | 822.07% |
| 2019 | 14 Million CNY | 0.0% |
| 2018 | 14 Million CNY | -47.66% |
| 2017 | 26.75 Million CNY | 167.5% |
| 2016 | 10 Million CNY | -33.33% |
| 2015 | 15 Million CNY | -73.87% |
| 2014 | 57.4 Million CNY | -45.4% |
| 2013 | 105.13 Million CNY | 251.61% |
| 2012 | 29.9 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 128.05 Million CNY | -40.31% |
| 2024 Q1 | 214.52 Million CNY | 273.61% |
| 2024 Q3 | 127.4 Million CNY | -0.51% |
| 2023 Q2 | 127.79 Million CNY | -11.41% |
| 2023 Q1 | 144.25 Million CNY | 361.8% |
| 2023 FY | 62.25 Million CNY | 99.3% |
| 2023 Q4 | 62.25 Million CNY | -51.18% |
| 2023 Q3 | 127.53 Million CNY | -0.21% |
| 2022 Q3 | 116.77 Million CNY | -1.12% |
| 2022 Q1 | 103.99 Million CNY | -36.98% |
| 2022 Q2 | 118.09 Million CNY | 13.56% |
| 2022 FY | 31.23 Million CNY | -81.07% |
| 2022 Q4 | 31.23 Million CNY | -73.25% |
| 2021 Q4 | 165.01 Million CNY | -25.45% |
| 2021 FY | 165.01 Million CNY | 27.83% |
| 2021 Q2 | 221.55 Million CNY | 6.94% |
| 2021 Q3 | 221.35 Million CNY | -0.09% |
| 2021 Q1 | 207.17 Million CNY | 60.48% |
| 2020 Q4 | 129.09 Million CNY | 830.71% |
| 2020 Q2 | 13.87 Million CNY | -0.93% |
| 2020 Q1 | 14 Million CNY | 0.0% |
| 2020 FY | 129.09 Million CNY | 822.07% |
| 2020 Q3 | 13.87 Million CNY | 0.0% |
| 2019 Q3 | 14 Million CNY | 0.0% |
| 2019 Q2 | 14 Million CNY | 0.0% |
| 2019 Q4 | 14 Million CNY | 0.0% |
| 2019 Q1 | 14 Million CNY | 0.0% |
| 2019 FY | 14 Million CNY | 0.0% |
| 2018 Q1 | 14 Million CNY | -47.66% |
| 2018 FY | 14 Million CNY | -47.66% |
| 2018 Q4 | 14 Million CNY | 0.0% |
| 2018 Q3 | 14 Million CNY | 0.0% |
| 2018 Q2 | 14 Million CNY | 0.0% |
| 2017 Q3 | 61 Million CNY | 0.0% |
| 2017 Q4 | 26.75 Million CNY | -56.15% |
| 2017 FY | 26.75 Million CNY | 167.5% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 61 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | 10 Million CNY | 0.0% |
| 2016 FY | 10 Million CNY | -33.33% |
| 2015 FY | 15 Million CNY | -73.87% |
| 2014 FY | 57.4 Million CNY | -45.4% |
| 2013 FY | 105.13 Million CNY | 251.61% |
| 2012 FY | 29.9 Million CNY | 0.0% |